References

  1. K/DOQI. clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002 Feb; 39 (2 Suppl 1): S1-266. PubMed | Google Scholar

  2. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001 Dec; 12(12):2753-8. PubMed | Google Scholar

  3. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S131-8. PubMed | Google Scholar

  4. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009 Jul; 24(7):2117-23. PubMed | Google Scholar

  5. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007 Nov 7; 298(17):2038-47. PubMed | Google Scholar

  6. Sumaili EK, Krzesinski JM, Zinga CV, Cohen EP, Delanaye P, et al. Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009 Jan; 24(1):117-22. PubMed | Google Scholar

  7. Afolabi MO, Abioye-Kuteyi AE, Arogundade FA, Bello IS. Prevalence of chronic kidney disease in a Nigerian family practice population. South African Family Practice. 2009; 51(2):132-137. PubMed | Google Scholar

  8. Adetuyibi A, Akisanya JB, Onadeko BO. Analysis of the causes of death on the medical wards of the University College Hospital, Ibadan over a 14 year period. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1976; 70(5-6): 466-73. PubMed | Google Scholar

  9. Akinsola W, Odesanmi WO, Ogunniyi JO, Ladipo GO. Diseases causing chronic renal failure in Nigerians - a prospective study of 100 cases. Afr J Med Med Sci. 1989 Jun;18(2):131-7. PubMed | Google Scholar

  10. Plange-Rhule J, Phillips R, Acheampong JW, Saggar-Malik AK, et al. Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens.1999 Jan; 13(1):37-40. PubMed | Google Scholar

  11. Osafo C, Mate-Kole M, Affram K, Adu D. Prevalence of chronic kidney disease in Hypertensive patients in Ghana. Renal Failure. 2011; 33(4): 388-392. PubMed | Google Scholar

  12. Mate - Kole M, Affram K, Lee SJ, Howie AJ, Michael J, Adu D. Hypertension and end stage renal failure in tropical Africa. J Hum Hypertens.1993;7 (5):443-446. PubMed | Google Scholar

  13. Lengani A, Laville M, Serme D, Fauvel JP, Ouandaogo BJ, Zech P. Renal insufficiency in arterial hypertension in black Africa. Presse Med. 1994 April 30-May 7; 23(17):788-92. PubMed | Google Scholar

  14. Ojo OS, Akinsola AA, Nwosu SO, Odesanmi WO. The pathological basis of chronic renal failure in Nigerians; An autopsy study. Trop Geogr Med. 1992 Jan; 44(1-2): 42-6. PubMed | Google Scholar

  15. Eghan BA, Amoako-Atta K, Kankam CA, Nsiah-Asare A. Survival pattern of hemodialysis patients in Kumasi, Ghana: a summary of forty patients initiated on hemodialysis at a new hemodialysis unit. Hemodial Int. 2009 Oct; 13(4): 467-71. PubMed | Google Scholar

  16. Osman EM, Abboud OI, Danielson BG. Chronic renal failure in Khartoum, Sudan. Ups J Med Sci. 1987; 92(1):65-73. PubMed | Google Scholar

  17. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH Consensus conference statement. Ann Intern Med. 1994 Jul 1; 121(1):62-70. PubMed | Google Scholar

  18. Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, Paul LC, Hons RB, Burgess ED. Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis. 1993 Jun;181(6):371-6. PubMed | Google Scholar

  19. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis. 1996 Dec;28(6):841-5. PubMed | Google Scholar

  20. Goicoechea M, De- Vinuesa SG, Gomez-Campdera F, Luno J. Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney Int Suppl. 2005 Jan;(93): S35-8. PubMed | Google Scholar

  21. Agarwal R, Light RP. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease. Clin J Am Soc Nephrol. 2011 Mar; 6(3): 528-36. PubMed | Google Scholar

  22. Ulasi II, Ijoma CK. The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in South - East Nigeria. J Trop Med. 2010 Jun; 2010: 501957. PubMed | Google Scholar

  23. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006 Mar 9; 354(10):997-9. PubMed | Google Scholar

  24. K/DOQI. clinical practice guidelines on hypertension and anti-hypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004 May; 43(5 Suppl 1): S1-290. PubMed | Google Scholar

  25. Excell L, McDonald S. Method and location of dialysis pp 25-33. ANZDATA Registry Report 2004. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia. PubMed | Google Scholar

  26. Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl. 2003 Feb; 83: S119-22. PubMed | Google Scholar

  27. Gibbs CR, Beevers DG, Lip GYH. The management of hypertensive disease in Black patients. Q J Med. 1999; 92(4): 187-92. PubMed | Google Scholar

  28. Young BA, Katon WJ, Von Korff M, et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol. 2005;16(1): 219-228. PubMed | Google Scholar

  29. Sarfo FS, Keegan R, Appiah L, Shakoor S, Phillips R, Norman B, Hardy Y, et al. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. J Infect. 2013 Jul;67(1):43-50. PubMed | Google Scholar

  30. Cappuccio FP, Micah FB, Emmett L, Kerry SM, Antwi S, et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004 May;43(5):1017-22. PubMed | Google Scholar

  31. Ayo A. Problems of haemodialysis in the management of chronic renal failure in Ibadan. Arch Ibadan Med. 2001; 2:14-16. PubMed | Google Scholar

  32. Akinsola A, Durosinmi MO, Akinola NO. The haematological profile of Nigerians with chronic renal failure. Afr J Med Med Sci. 2000 Mar;29(1):13-6. PubMed | Google Scholar

  33. Oluboyede OA, Williams AI. Serum ferritin and other iron indices in adult Nigerians with chronic renal failure--review of management of anaemia. Afr J Med Med Sci. 1995 Sep;24(3):231-7. PubMed | Google Scholar

  34. Collins AJ, Li S, Peter W, Ebben J, Roberts T, Jennie ZMA, Manning W. Death, hospitalization, and economic associations among incident hemodialysis patients with haematocrit value of 36-39%. J Am Soc Nephrol. 2001 Nov;12(11): 2465-73. PubMed | Google Scholar

  35. Walker WG, Neaton JD, Cutler JA, Newwirth R, Cohen JD. Renal function change in hypertensive members of Multiple Risk Factor Intervention Trial; Racial and treatment effects; The MRFIT Research Group. JAMA. 1992 Dec; 268(21):3085-91. PubMed | Google Scholar

  36. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. Effect of blood pressure lowering and anti-hypertensive drug class on progression of hypertensive kidney disease: results from AASK trial. JAMA. 2002 Nov; 288(19):2421-31. PubMed | Google Scholar

  37. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int. 2006 Mar; 69(6): 967-73. PubMed | Google Scholar